InnoPinnacle Fund

InnoPinnacle Fund (Suzhou Xinhao Guoqing Fund) is a venture capital fund jointly initiated by Innovent Biologics and Oriza Holdings as general partners, and operated primarily by Innovent Biologics. The fund manager is Suzhou Xincheng Private Equity Fund Management Co., Ltd. ("Xincheng Fund"). The fund aims to actively implement the national innovation development strategy, focus on cutting-edge development opportunities in the life and health industry, leverage industrial strengths and unique advantages, and support the high-quality development of innovative enterprises. The fund concentrates on investing in leading companies in the fields of innovative drugs, biotechnology, and related industrial chains, with a particular emphasis on empowering next-generation biopharmaceuticals and breakthrough technologies to address unmet clinical needs.